Literature DB >> 27069420

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.

Michael Desborough1, Lise J Estcourt1, Anna Chaimani2, Carolyn Doree3, Sally Hopewell4, Marialena Trivella5, Andreas V Hadjinicolaou6, Paresh Vyas7, Simon J Stanworth8.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the relative efficacy of different treatments for thrombocytopenia (artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, rFXIII, thrombopoietin mimetics, antifibrinolytic drugs or platelet transfusions) in patients with chronic bone marrow failure and to derive a hierarchy of potential alternate treatments to platelet transfusions.

Entities:  

Year:  2016        PMID： 27069420      PMCID： PMC4826602          DOI： 10.1002/14651858.CD012055

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  60 in total

1.  Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  C A Schiffer; K C Anderson; C L Bennett; S Bernstein; L S Elting; M Goldsmith; M Goldstein; H Hume; J J McCullough; R E McIntyre; B L Powell; J M Rainey; S D Rowley; P Rebulla; M B Troner; A H Wagnon
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Guidelines for the use of platelet transfusions.

Authors: 
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

3.  Transfusion guidelines for neonates and older children.

Authors:  Brenda E S Gibson; Audrey Todd; Irene Roberts; Derwood Pamphilon; Charles Rodeck; Paula Bolton-Maggs; Geoff Burbin; J Duguid; F Boulton; H Cohen; N Smith; D B L McClelland; M Rowley; G Turner
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

4.  Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.

Authors:  A-M Tsimberidou; F J Giles; I Khouri; C Bueso-Ramos; S Pilat; D A Thomas; J Cortes; R Kurzrock
Journal:  Ann Oncol       Date:  2005-01       Impact factor: 32.976

5.  The epidemiology of aplastic anemia in Thailand.

Authors:  Surapol Issaragrisil; David W Kaufman; Theresa Anderson; Kanchana Chansung; Paul E Leaverton; Samuel Shapiro; Neal S Young
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  Pilot study of low-dose interleukin-11 in patients with bone marrow failure.

Authors:  R Kurzrock; J Cortes; D A Thomas; S Jeha; S Pilat; M Talpaz
Journal:  J Clin Oncol       Date:  2001-11-01       Impact factor: 44.544

7.  Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications.

Authors:  P Gupta; S C LeRoy; S D Luikart; A Bateman; V A Morrison
Journal:  Leuk Res       Date:  1999-10       Impact factor: 3.156

8.  The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation.

Authors:  K R Muir; C E D Chilvers; C Harriss; L Coulson; M Grainge; P Darbyshire; C Geary; J Hows; J Marsh; T Rutherford; M Taylor; E C Gordon-Smith
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

Review 9.  The incidence and impact of thrombocytopenia in myelodysplastic syndromes.

Authors:  Hagop Kantarjian; Francis Giles; Alan List; Roger Lyons; Mikkael A Sekeres; Sherry Pierce; Robert Deuson; Joseph Leveque
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

10.  Myelodysplastic syndromes: incidence and survival in the United States.

Authors:  Xiaomei Ma; Monique Does; Azra Raza; Susan T Mayne
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860
View more
  4 in total

1.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Marialena Trivella; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

Review 2.  Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.

Authors:  Michael Desborough; Andreas V Hadjinicolaou; Anna Chaimani; Marialena Trivella; Paresh Vyas; Carolyn Doree; Sally Hopewell; Simon J Stanworth; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-10-31

Review 3.  Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Authors:  Michael Desborough; Lise J Estcourt; Carolyn Doree; Marialena Trivella; Sally Hopewell; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

Review 4.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Reem Malouf; Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.